Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Vopr Onkol ; 57(6): 742-7, 2011.
Article in Russian | MEDLINE | ID: mdl-22416391

ABSTRACT

A retrospective evaluation of progesterone (PR) and alpha-estrogen (ER) expression was carried out in 16 patients with smooth muscle tumors with uncertain potential of malignancy (STUMP) and 76 patients with uterine leiomyosarcoma (ULMS). PR expression was observed in 100% of intact myometrium and leiomyoma samples, while ER was expressed only in 37.1 +/- 4.2% and 23.5 +/- 4.1% of samples. In STUMP samples PR expression was observed in 66.7 +/- 11.7% of cases, in ULMS samples in 50.5 +/- 5.7% of cases. However, there was an inverse correlation between malignancy grade and sex hormones expression, although the number of positive cells and staining intensity didn't prove to be independent risk factors. The patients with ULMS G1 and STUMP expressing sex hormones have favorable prognosis, while negative receptor status of STUMP tumors is the marker of the worse prognosis.


Subject(s)
Biomarkers, Tumor/analysis , Endometrial Neoplasms/chemistry , Endometrial Neoplasms/diagnosis , Leiomyoma/chemistry , Leiomyoma/diagnosis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Adult , Aged , Cell Transformation, Neoplastic/chemistry , Cell Transformation, Neoplastic/pathology , Diagnosis, Differential , Endometrial Neoplasms/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Leiomyoma/pathology , Middle Aged , Predictive Value of Tests , Prognosis , Retrospective Studies
2.
Arkh Patol ; 71(4): 50-3, 2009.
Article in Russian | MEDLINE | ID: mdl-19824432

ABSTRACT

The immunohistochemical technique was used to study the levels progesterone and estrogen-alpha receptors in the smooth muscle cells, by examining the specimens taken from 168 leiomyosarcomas (LMS) and 106 leiomyomas (LM) of the corpus uteri. The presence and degree of receptor expression were shown to be related to the proliferative activity (PA) (Ki67 protein expression), the activity of argyrophilic proteins in the nucleolar organizer region (Ag-NOR-protein) (silver-plating with AgNO3, as described by Y. Daskal) and the proteins regulating the apoptotic system (Bcl-2 expression) (93.4 +/- 1.1%). The presence of sex hormone receptors in LMS was associated with low PA (8.5 +/- 3.3%), the decreased synthesis of Ag-NOR proteins (15.1 +/- 2.7%), and high Bcl-2 activity (93.4 +/- 1.1%) although the presence of the receptors had no significant effect on p53. The negative expression of both types of receptors was characteristic for LMS and associated with high PA (19.3 +/- 3.1%), the high expression of Ag-NOR-proteins (25.3 +/- 2.6%), and a drastic reduction in the amplification of Bcl-2 (38.4 +/- 10%) in reference to the positive receptor status. Receptor coexpression was associated with relatively low PA, the expression of argyrophilic proteins and the relatively high expression Bcl-2 without any noticeable impact on the expression of p53.


Subject(s)
Biomarkers, Tumor/metabolism , Estrogen Receptor alpha/metabolism , Leiomyosarcoma/metabolism , Nucleolus Organizer Region/metabolism , Receptors, Progesterone/metabolism , Uterine Neoplasms/pathology , Female , Humans , Ki-67 Antigen/metabolism , Leiomyosarcoma/pathology , Nucleolus Organizer Region/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Tumor Suppressor Protein p53/metabolism , Uterine Neoplasms/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL